Severe Eosinophilic Asthma Completed Phase 2 Trials for OC-459 (DB11900)

IndicationStatusPhase
DBCOND0078144 (Severe Eosinophilic Asthma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02560610Effect of OC000459 on Eosinophilic Airway Inflammation in Severe AsthmaTreatment